
AI for Biotech: A Build vs. Buy Decision Framework
A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, and vendor evaluation criteria.

A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, and vendor evaluation criteria.

A technical overview of Claude Opus 4.5, a state-of-the-art AI model for coding. Learn its capabilities for software development in healthcare and pharma.

An in-depth analysis of Veeva AI Agents, the agentic AI integrated into the Veeva Vault platform for life sciences. Learn about its architecture, use cases, and